Global Viscosupplementation Market Insights, Revenue Analysis, and Future Outlook | Valuates Reports

The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Is the Viscosupplementation Market Growth Forecast from 2026 to 2030?
The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis, increasing geriatric population, advancements in joint care therapies, growing awareness of viscosupplementation, expanding orthopedic healthcare infrastructure.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to adoption of regenerative medicine, integration of digital health monitoring, development of novel hyaluronic acid formulations, expansion of ambulatory surgical centers, rising investments in outpatient orthopedic procedures. Major trends in the forecast period include minimally invasive joint therapies, regenerative medicine integration, personalized osteoarthritis treatment, injectable hyaluronic acid innovations, outpatient orthopedic procedures.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Who Are the Major Contributors to the Viscosupplementation Market Growth?
The rise in the prevalence of osteoarthritis is expected to propel the growth of the viscosupplementation market going forward. Osteoarthritis refers to a degenerative joint disease, also known as a common form of arthritis, in which the joints start to break down, mostly in the hips, knees, and hands. Viscosupplementation treatment helps to reduce pain and facilitate smooth bone movement by injecting hyaluronic acid straight into the bone joints, which enables a reduction in pain and improves the bone’s functionality. For instance, in August 2023, according to Institute for Health Metrics and Evaluation (IHME), a US-based nonprofit global health research center, reported that by 2050, osteoarthritis of the knee will increase by 75%, and osteoarthritis of the hand by 50%. Therefore, the rise in the prevalence of osteoarthritis is driving the growth of the viscosupplementation market going forward.

Which Are the Leading Segments in the Viscosupplementation Market?
The viscosupplementation market covered in this report is segmented –

1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products

Which Trends Are Most Likely to Influence Viscosupplementation Market Growth in the Next Decade?
Major companies operating in the viscosupplementation market are focused on developing innovative products such as resorbable, hyaluronic acid scaffolds to enhance joint lubrication, promote tissue regeneration, and provide long-lasting relief from osteoarthritis symptoms, thereby improving patient outcomes and expanding treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made primarily from hyaluronic acid (HA), a naturally occurring polysaccharide found in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a US-based company that offers orthopedics introduced Hyalofast, a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair. Hyalofast is designed to provide a hyaluronic acid-based solution aimed at joint preservation, potentially offering an alternative to more invasive surgical procedures.

Which Are the Key Companies Shaping the Viscosupplementation Market Landscape?
Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

Get the full viscosupplementation market report here:
https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Which Regions Are Driving the Most Demand in the Viscosupplementation Market?
North America was the largest region in the viscosupplementation market in 2025. The regions covered in the viscosupplementation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn